Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Schizophrenia

  Free Subscription


21.04.2020

1 Biol Psychiatry
2 J Clin Psychiatry
2 J Nerv Ment Dis
3 Mol Psychiatry
1 Neuropsychopharmacology
1 Psychiatry Res
1 Psychol Med
6 Schizophr Res


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Biol Psychiatry

  1. SANFELICI R, Dwyer DB, Antonucci LA, Koutsouleris N, et al
    Individualized Diagnostic and Prognostic Models for Patients With Psychosis Risk Syndromes: A Meta-analytic View on the State of the Art.
    Biol Psychiatry. 2020 Feb 20. pii: S0006-3223(20)30098.
    PubMed         Abstract available


    J Clin Psychiatry

  2. CORRELL CU
    Current Treatment Options and Emerging Agents for Schizophrenia.
    J Clin Psychiatry. 2020;81.
    PubMed         Abstract available

  3. CORRELL CU
    Using Patient-Centered Assessment in Schizophrenia Care: Defining Recovery and Discussing Concerns and Preferences.
    J Clin Psychiatry. 2020;81.
    PubMed         Abstract available


    J Nerv Ment Dis


  4. Facilitating the Delivery of Cognitive Remediation in First-Episode Psychosis: Pilot Study of a Home-Delivered Web-Based Intervention: Erratum.
    J Nerv Ment Dis. 2020;208:439.
    PubMed        

  5. ALLEN AR, Hagen KM
    Trauma and Suicide: A Pilot Study Assessing Risk in Adults Diagnosed With Schizophrenia Spectrum Disorders.
    J Nerv Ment Dis. 2020;208:431-434.
    PubMed         Abstract available


    Mol Psychiatry

  6. MARQUES TR, Ashok AH, Angelescu I, Borgan F, et al
    GABA-A receptor differences in schizophrenia: a positron emission tomography study using [(11)C]Ro154513.
    Mol Psychiatry. 2020 Apr 15. pii: 10.1038/s41380-020-0711.
    PubMed         Abstract available

  7. KOSHIYAMA D, Fukunaga M, Okada N, Morita K, et al
    Differences in fractional anisotropy between the patients with schizophrenia and healthy comparison subjects.
    Mol Psychiatry. 2020;25:697-698.
    PubMed        

  8. LICINIO J
    Advances in schizophrenia research: first special issue, 2020.
    Mol Psychiatry. 2020;25:699-700.
    PubMed        


    Neuropsychopharmacology

  9. YAO L, Li F, Liu J, Liao W, et al
    Correction: Functional brain networks in never-treated and treated long-term Ill schizophrenia patients.
    Neuropsychopharmacology. 2020 Apr 17. pii: 10.1038/s41386-020-0673.
    PubMed         Abstract available


    Psychiatry Res

  10. ZANDIFAR A, Badrfam R
    COVID-19: Considering the prevalence of schizophrenia in the coming decades.
    Psychiatry Res. 2020;288:112982.
    PubMed        


    Psychol Med

  11. BURGER TJ, Schirmbeck F, Vermeulen JM, Quee PJ, et al
    Association between cognitive phenotype in unaffected siblings and prospective 3- and 6-year clinical outcome in their proband affected by psychosis.
    Psychol Med. 2020 Apr 15:1-11. doi: 10.1017/S0033291720000719.
    PubMed         Abstract available


    Schizophr Res

  12. BARRY AB, Koeppel JA, Ho BC
    Impulsive decision making, brain cortical thickness and familial schizophrenia risk.
    Schizophr Res. 2020 Apr 15. pii: S0920-9964(20)30206.
    PubMed         Abstract available

  13. PAQUIN V, Lemire M, King S
    Ecosystem approaches to the risk for schizophrenia.
    Schizophr Res. 2020 Apr 10. pii: S0920-9964(20)30168.
    PubMed        

  14. VERNAL DL, Boldsen SK, Lauritsen MB, Correll CU, et al
    Long-term outcome of early-onset compared to adult-onset schizophrenia: A nationwide Danish register study.
    Schizophr Res. 2020 Apr 13. pii: S0920-9964(20)30155.
    PubMed         Abstract available

  15. VIHER PV, Stegmayer K, Federspiel A, Bohlhalter S, et al
    Altered diffusion in motor white matter tracts in psychosis patients with catatonia.
    Schizophr Res. 2020 Apr 12. pii: S0920-9964(20)30120.
    PubMed         Abstract available

  16. MINICHINO A, Brondino N, Solmi M, Del Giovane C, et al
    The gut-microbiome as a target for the treatment of schizophrenia: A systematic review and meta-analysis of randomised controlled trials of add-on strategies.
    Schizophr Res. 2020 Apr 12. pii: S0920-9964(20)30101.
    PubMed         Abstract available

  17. QIAN N, Lipkin RM, Kaszowska A, Silipo G, et al
    Computational modeling of excitatory/inhibitory balance impairments in schizophrenia.
    Schizophr Res. 2020 Apr 11. pii: S0920-9964(20)30133.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: